Plasma Cell Neoplasms Tables: Recurrent Cytogenomic Alterations: Difference between revisions
| [unchecked revision] | [unchecked revision] |
Added Table 1 commentary |
Adding gene links |
||
| Line 15: | Line 15: | ||
|t(4;14) | |t(4;14) | ||
|Poor prognosis, predicts bortezomib response | |Poor prognosis, predicts bortezomib response | ||
|''IGH'' | |''[[IGH]]'' | ||
|- | |- | ||
|t(6;14) | |t(6;14) | ||
|Good prognosis | |Good prognosis | ||
|''IGH'' | |''[[IGH]]'' | ||
|- | |- | ||
|t(14;16) | |t(14;16) | ||
|Poor prognosis | |Poor prognosis | ||
|''IGH'' | |''[[IGH]]'' | ||
|- | |- | ||
|t(11;14) | |t(11;14) | ||
|Good prognosis | |Good prognosis | ||
|''IGH'' | |''[[IGH]]'' | ||
|- | |- | ||
|t(14;20) | |t(14;20) | ||
| Line 90: | Line 90: | ||
|8q24.2+ | |8q24.2+ | ||
|Recurrent | |Recurrent | ||
|''MYC'' | |''[[MYC]]'' | ||
|- | |- | ||
|9p+ | |9p+ | ||
| Line 98: | Line 98: | ||
|del(10q23.31) | |del(10q23.31) | ||
|Recurrent | |Recurrent | ||
|''PTEN'' | |''[[PTEN]]'' | ||
|- | |- | ||
|11q+ | |11q+ | ||
| Line 110: | Line 110: | ||
|del(13q32.2) | |del(13q32.2) | ||
|Recurrent | |Recurrent | ||
|''TGDS'' | |''[[TGDS]]'' | ||
|- | |- | ||
|del(14q) | |del(14q) | ||
| Line 154: | Line 154: | ||
|22q21+ | |22q21+ | ||
|Associated with relapse | |Associated with relapse | ||
|''PRAME'' | |''[[PRAME]]'' | ||
|- | |- | ||
|del(X), X+, X CN-LOH | |del(X), X+, X CN-LOH | ||
| Line 690: | Line 690: | ||
| 17p13 | | 17p13 | ||
|Loss | |Loss | ||
|''[[ATP1B2]], | |''[[ATP1B2]], [[TP53]], [[WRAP5]], [[EFNB3]]'' | ||
| Predictive & prognostic | | Predictive & prognostic | ||
|1 | |1 | ||